As of early 2026, there is no finalized settlement in The Ordinary labeling lawsuit that customers can claim from. What exists instead is an unresolved situation: widespread reports of chemical burns and skin injuries from The Ordinary’s AHA 30% + BHA 2% Peeling Solution dating back to 2020-2021, combined with discussions of a potential class action lawsuit, but no official settlement agreement, approved court order, or established payout amounts. Customers who believe they were harmed by this product have not yet received compensation through a formal settlement process. This article explains what is actually known about The Ordinary product liability situation, why no settlement has been finalized, and what injured consumers can do right now to protect their interests.
The core issue centers on product labeling and safety warnings. Users reported severe chemical burns and skin damage from the peel-off mask, alleging the product lacked adequate warnings about application time, dilution, and potential adverse reactions. While these reports circulated widely online, the case has not moved to a finalized settlement phase with specific claim payouts. This gap between injury reports and settlement reality is important: if you were injured, you need to understand that claiming compensation is not yet possible through a standard settlement claims process.
Table of Contents
- What Actually Happened with The Ordinary Peeling Solution
- Why There Is No Finalized Settlement Yet
- What Customers Have Reported About Their Injuries
- How to Determine If You Qualify for Compensation
- The Challenge of Proving Product Liability in Cosmetics Cases
- Regulatory Actions and FDA Involvement
- What to Do Now and Future Outlook
What Actually Happened with The Ordinary Peeling Solution
The Ordinary, a brand owned by Deciem (which is owned by Estée Lauder), sells an affordable AHA 30% + BHA 2% Peeling Solution marketed as an exfoliant for advanced skincare users. Between 2020 and 2021, multiple customers reported severe adverse reactions—chemical burns, persistent redness, skin blistering, and deep dermatological damage—that they attributed to inadequate warning labels. These weren’t isolated complaints: discussion threads across Reddit, skincare forums, and product review sites documented dozens of reported injuries, with users describing application times that resulted in chemical burns even with shorter exposure than the label suggested.
The injury reports triggered discussions about whether the product’s labeling was sufficient. Critics argued the label did not adequately warn that even brief contact could cause chemical burns, that it did not recommend performing a patch test first, and that dilution instructions were missing or unclear. Unlike consumer injuries from major pharmaceuticals or medical devices, these complaints never coalesced into a large-scale, publicly announced class action settlement. No major law firm publicly launched a class action with widespread marketing, no court issued a settlement approval order, and no settlement claims website or deadline was established.
Why There Is No Finalized Settlement Yet
Multiple factors explain why no finalized settlement exists despite the injury reports. First, product liability cases involving cosmetics move slowly through courts, especially when they involve chemical reactions that may be user-dependent (application time, skin sensitivity, pre-existing conditions). The burden falls on plaintiffs to prove that the labeling was materially inadequate and that the inadequacy directly caused their injury—not an easy legal threshold.
Second, if litigation began in 2020-2021, the case may still be in discovery, motion phases, or settlement negotiations, which can take years before a court-approved settlement is announced. However, there is an important caveat: it’s also possible the settlement simply has not been widely publicized online, or details may be under confidentiality agreements known primarily to attorneys and claimants already enrolled. Smaller settlements, especially for consumer products with dispersed injury claims, sometimes don’t achieve high online visibility. If you suffered injury from this product, it’s worth checking directly with law firms that specialize in product liability or contacting consumer protection agencies rather than relying on search results.
What Customers Have Reported About Their Injuries
Documented complaints in online forums describe a consistent pattern. One user reported applying the mask and removing it after five minutes as instructed, then experiencing intense burning and redness that persisted for weeks. Another described blistering on the cheeks and nose after a single application. Some reported that the burning sensation did not stop with water rinsing but continued for hours.
A subset of complaints included reports of post-inflammatory hyperpigmentation (darkening of the skin) as a long-term consequence of the chemical burn. These accounts were not isolated—enough complaints accumulated that skincare communities began flagging the product as high-risk and recommending extreme caution or avoidance. The pattern suggests the issue was not limited to one manufacturing batch or user error alone. When similar injuries are reported across many users in different locations, it points to a product design or labeling issue rather than individual accident. Importantly, these injury reports circulated widely in 2020-2021, yet no formal acknowledgment, recall, or label update from the company was announced publicly.
How to Determine If You Qualify for Compensation
If you suffered a skin injury you believe was caused by The Ordinary AHA/BHA product, your first step is documenting the injury: photographs of the damage, dated medical records from a dermatologist or doctor, purchase receipts, and a detailed timeline of what happened. Having this documentation in order matters whether or not a settlement exists today—medical evidence will be required if you pursue a claim later. Next, actively search for settlement information rather than waiting for marketing outreach.
Check PACER (Public Access to Court Electronic Records) at pacer.gov to search federal court filings by product name, brand, or defendant name “Deciem” or “The Ordinary.” Contact product liability law firms directly—many offer free consultations to evaluate potential claims. Some firms specialize in cosmetic injury cases and will investigate on your behalf. You can also file a complaint with the FDA and your state’s attorney general’s office; while these don’t create a settlement, they establish a record that may support future litigation.
The Challenge of Proving Product Liability in Cosmetics Cases
Product liability in cosmetics cases faces unique hurdles compared to pharmaceuticals. Cosmetics are not subject to FDA pre-approval like drugs; they reach consumers with weaker regulatory oversight. This means the bar for proving a company’s liability is higher—you must show not just that you were injured, but that the labeling was materially deceptive or failed to warn of a foreseeable risk.
If The Ordinary’s label warned “do not use if sensitive to acids” or “rinse immediately if burning occurs,” the company may argue that users who did not follow warnings bear responsibility. However, there is a critical limitation: if the label did not warn of the *severity* of possible damage (chemical burns, permanent scarring, or long-term hyperpigmentation), or if it recommended an application time that was actually unsafe even for non-sensitive skin, that becomes the company’s liability. For example, if the label said “apply for up to 10 minutes” but caused severe burns within 5 minutes for typical users, the inadequacy is with the label itself, not user error.
Regulatory Actions and FDA Involvement
The FDA has issued advisories about The Ordinary products in certain markets. In 2024, the Philippine FDA issued a public health warning against the purchase and use of “unnotified cosmetic the ordinary aha 30 bha 2 peeling solution,” citing it as an unregistered product. This suggests regulatory scrutiny exists in some jurisdictions, though it does not directly translate to a U.S. settlement.
U.S. consumers should monitor FDA announcements and their state attorney general’s websites for any recall notices or settlement information. Additionally, if The Ordinary or its parent company issued any quiet label changes, product reformulations, or recalls in certain markets, this may indicate internal acknowledgment of safety concerns. Such actions can become important evidence in litigation.
What to Do Now and Future Outlook
For now, the most actionable step is to preserve your evidence of injury and begin documenting your case independently. If you were harmed and have medical records, create a file with photos, receipts, dermatology reports, and a written timeline.
Contact a product liability attorney to evaluate your claim even if no public settlement yet exists—the attorney can advise whether to wait for a class action to be announced, pursue an individual claim, or negotiate a settlement directly. Looking ahead, if you search for settlement information in 2026 and beyond and find a class action website or settlement announcement, that would be the time to file your claim within the deadline. Until then, the injury reports and legal discussions remain in limbo—enough evidence to suggest a legitimate product problem, but not yet formalized into a compensable settlement.